Shanghai Pharmaceutical Ruier Pharmaceutical

Shanghai Pharmaceutical Ruier Pharmaceutical is a specialized subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) dedicated to the development and supply of medications for rare diseases, often referred to as orphan drugs. As a key component of SPH's rare disease strategy, the company focuses on ensuring the availability of essential treatments for conditions with high unmet medical needs in China. Its portfolio includes critical therapies for Wilson's disease and other metabolic disorders, as well as emergency medicines. The company integrates research, development, and manufacturing to provide high-quality, affordable solutions for patients with rare conditions.